Leptin- or troglitazone-induced lipopenia protects islets from interleukin 1β cytotoxicity

Journal of Clinical Investigation

Volumn 100, Issue 7, 1997, Pages 1750-1754

  Shimabukuro, Michio ^a,b,c   Koyama, Kazunori ^a,b,c   Lee, Young ^a,b,c   Unger, Roger H ^a,b,c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

Author keywords

Diabetes; Interleukin 1 ; Leptin; Obesity; Troglitazone

Indexed keywords

INTERLEUKIN 1BETA; LEPTIN; NITRIC OXIDE; TRIACYLGLYCEROL; TROGLITAZONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CYTOTOXICITY; DOSE RESPONSE; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT;

EID: 0030885230     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119700     Document Type: Article

References (23)

1. Mandrup-Poulsen, T. 1996. The role of interleukin-1 in the pathogenesis of IDDM. Diabetologia. 39:1005-1029.
2. Bendtzen, K., T. Mandrup-Poulsen, J. Nerup, J.H. Nielsen, C.A. Dinarello, and M. Svenson. 1986. Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans. Science (Wash. DC). 232:1545-1547.
3. McDaniel, M.L., G. Kwon, J.R. Hill, C.A. Marshall, and J.A. Corbett. 1996. Cytokines and nitric oxide in islet inflammation and diabetes. Proc. Soc. Exp. Biol. Med. 211:24-32.
4. Kröncke, K.D., V. Kolb-Bachofen, B. Berschick, V. Burkart, and H. Kolb. 1991. Activated macrophages kill pancreatic syngeneic islet cells via arginine-dependent nitric oxide generation. Biochem. Biophys. Res. Commun. 175: 757-758.
5. Eizirik, D.L., C.A. Delaney, M.H.L. Green, J.M. Cunningham, J.R. Thorpe, D.G. Pipeleers, C. Hellerstrom, and I.C. Green. 1996. Nitric oxide donors decrease the function and survival of human pancreatic islets. Mol. Cell. Endocrinol. 118:71-83.
6. Corbett, J.A., and M.L. McDaniel. 1992. Does nitric oxide mediate autoimmune destruction of β-cells? Possible therapeutic interventions in IDDM. Diabetes. 41:897-903.
7. Kleemann, R., H. Rothe, V. Kolb-Bachofen, Q.W. Xie, C. Nathan, S. Martin, and H. Kolb. 1993. Transcription and translation of inducible nitric oxide synthase in the pancreas of prediabetic BB rats. FEBS Lett. 328:9-12.
8. Corbett, J.A., A. Mikhael, J. Shimizu, K. Frederick, T.P. Misko, M.L. McDaniel, O. Kanagawa, and E.R. Unanue. 1993. Nitric oxide production in islets from nonobese diabetic mice: aminoguanidine-sensitive and -resistant stages in the immunological diabetic process. Proc. Natl. Acad. Sci. USA. 90: 8992-8995.
9. Lindsay, R.M., W. Smith, S.P. Rossiter, and M.A. McIntyre. 1995. N omega-nitro-L-arginine methyl ester reduces the incidence of IDDM in BB/E rats. Diabetes. 44:365-368.
10. Shimabukuro, M., M. Ohneda, Y. Lee, and R.H. Unger. 1997. Role of nitric oxide in obesity-induced β cell disease. J. Clin. Invest. 100:290-295.
11. Fulgencio, J.P., C. Kohl, J. Girard, and J.P. Pégorier. 1996. Troglitazone inhibits fatty acid oxidation and esterification, and gluconeogenesis in isolated hepatocytes from starved rats. Diabetes. 45:1556-1562.
12. Shimahukuro, M., K. Koyama, G. Chen, M.Y. Wang, F. Trieu, Y. Lee, C.B. Newgard, and R.H. Unger. 1997. Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc. Natl. Acad. Sci. USA. 94:4637-4641.
13. Phillips, M.S., Q.Y. Liu, H.A. Hammond, V. Dugan, P.J. Hey, C.T. Caskey, and J.F. Hess. 1996. Leptin receptor missense mutation in the fatty Zucker rat. Nat. Genet. 13:18-19.
14. Chen, G., K. Koyama, X. Yuan, Y. Lee, Y.T. Zhou, R. O'Doherty, C.B. Newgard, and R.H. Unger. 1996. Disappearance of body fat in normal rals induced by adenovirus-mediated leptin gene therapy. Proc. Natl. Acad. Sci. USA. 93:14795-14799.
15. Naber, S.P., J.M. McDonald, L. Jarett, M.L. McDaniel, C.W. Ludvigsen, and P.E. Lacy. 1980. Preliminary characterization of calcium binding in islet-cell plasma membranes. Diabetologia. 19:439-444.
16. Lee, Y., H. Hirose, M. Ohneda, J.H. Johnson, J.D. McGarry, and R.H. Unger. 1994. β-Cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-β-cell relationship. Proc. Natl. Acad Sci. USA. 91:10878-10882.
17. 15N]nitrate in biological fluids. Anal. Biochem. 126:131-138.
18. Marshall, N.J., C.J. Goodwin, and S.J. Holt. 1995. A critical assessment of the use of microculture tetrazolium assays to measure cell growth and function. Growth Regul. 5:69-84.
19. Lee, Y., H. Hirose, V.T. Zhou, V. Esser, J.D. McGarry, and R.H. Unger. 1997. Increased lipogenic capacity of the islets of obese rats - a role in the pathogenesis of NIDDM. Diabetes. 46:408-413.
20. Iida, M., T. Murakami, K. Ishida, A. Mizuno, M. Kuwajima, and K. Shima. 1996. Phenotype-linked amino acid alteration in leptin receptor cDNA from Zucker Fatty (fa/fa) rats. Biochem. Biophys. Res. Commun. 224:597-604.
21. Ohneda, M., L.R. Inman, and R.H. Unger. 1945. Caloric restriction in obese pre-diabetic rats prevents beta-cell depiction, loss of beta-cell GLUT 2 and glucose incompetence. Diabetologia, 38:173-179.
22. Yang, S.O., H.Z. Lin, M.D. Lane, M. Lemens, and A.M. Diehl. 1997. Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatilis. Proc. Natl. Acad. Sci. USA. 44:2557-2562.
23. Fujiwara, T., S. Yoshioka, T. Yoshioka, I. Uchiyama, and H. Horikoshi. 1988. Characterisation of new oral antidiahetic agent CS-045. Studies in KK and ob/ob mice and Zucker Fatty rats. Diabetes. 37:1549-1558.